Nature Reviews Neuroscience 13, 507–514 (2012)
On page 508 of this article, “alemtuzumab (a monoclonal antibody directed against CD25 (also known as interleukin-2 receptor subunit-α), which is expressed on leukocytes)” should have read “alemtuzumab (a monoclonal antibody directed against CD52, which is expressed on lymphocytes)”. This has been corrected in the online version.
Additional information
The online version of the original article can be found at 10.1038/nrn3275
Rights and permissions
About this article
Cite this article
Stys, P., Zamponi, G., van Minnen, J. et al. Erratum: Will the real multiple sclerosis please stand up?. Nat Rev Neurosci 13, 597 (2012). https://doi.org/10.1038/nrn3300
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrn3300
This article is cited by
-
Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis
Scientific Reports (2021)
